GlassScriptPhysician profile
Raechel A Leone
NPI 1306516398
$4,017.99
in general payments reported to CMS, 2019-2025
31 companies · $1,075 in 2025
The $1,075 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $746 · 2023: $843 · 2024: $1,238 · 2025: $1,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,155.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $503.59 | 2022-2025 | Lifevest |
| Amgen INC. | $490.38 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $483.23 | 2022-2025 | Watchman Flx, Ekosonic, Watchman Access System |
| Pfizer INC. | $368.86 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $258.48 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $239.03 | 2021-2025 | Brilinta, Wainua |
| Novartis Pharmaceuticals Corporation | $235.38 | 2022-2025 | |
| Scpharmaceuticals INC. | $193.05 | 2024-2025 | |
| Novo Nordisk INC | $162.88 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.12 | 2023-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $95.15 | 2025 | Assure Wcd |
| Biotronik INC. | $94.60 | 2024 | Renamic Neo, Biomonitor |
| Actelion Pharmaceuticals US, INC. | $89.02 | 2022-2024 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $84.24 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $75.48 | 2021-2024 | Xarelto |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $67.05 | 2022-2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $59.18 | 2021-2023 | Verquvo |
| Alnylam Pharmaceuticals INC. | $57.39 | 2022-2023 | Onpattro |
| Abiomed | $52.54 | 2024-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $32.48 | 2025 | |
| Cvrx, INC. | $31.04 | 2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $29.79 | 2025 | Sapien 3 Ultra Resilia |
| Cleerly, INC. | $26.06 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Heartflow, INC. | $24.11 | 2023 | Ffrct |
| Cmp Pharma, INC. | $23.06 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $20.30 | 2024 | |
| Bridgebio Pharma, INC. | $18.21 | 2025 | Attruby |
| Octapharma USA, INC. | $17.17 | 2025 | Fibryga |
| Angiodynamics, INC. | $16.94 | 2025 | Auryon Laser System 100-120 Vac |
| Regeneron Healthcare Solutions, INC. | $16.68 | 2025 | Evkeeza |
| Vivaquant INC, Dba Rhythm Express | $11.50 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raechel Leone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.